Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Amyloidosis topic

 

Articles

1-89 out of 89 article(s)
Title Author Type Date Words
Research and Markets: Amyloidosis - Pipeline Review, H1 2012. May 23, 2012 438
Research and Markets: Primary Systemic Amyloidosis - Pipeline Review, H1 2012. May 15, 2012 400
Research and Markets: Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019. May 10, 2012 377
Alnylam Presents Final Results from a Phase I Clinical Trial of ALN-TTR01, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of Transthyretin-Mediated Amyloidosis (ATTR). May 10, 2012 2387
ProteoTech's Chief Scientific Officer, Dr. Alan Snow, to Present New Data on "SystebrylTM for the Treatment of Systemic AA Amyloidosis" at the XIIIth International Symposium on Amyloidosis, Groningen, Netherlands, May 6-10, 2012. Apr 23, 2012 367
Skin disorders associated with monoclonal gammopathy. Pothiawala, Salma; Etzkorn, Jeremy Robert Table Apr 1, 2012 920
Alnylam Initiates Phase I Clinical Study of ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR). Mar 19, 2012 2041
Amyloidoses of dermatologic significance. Sigmon, Justin R. Report Feb 1, 2012 438
Alnylam Files Clinical Trial Application for ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin for the Treatment of Transthyretin-Mediated Amyloidosis. Jan 6, 2012 2069
Alnylam Presents Positive Preliminary Clinical Results for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis. Nov 21, 2011 2442
Alnylam to Present Phase I Clinical Data at VIIIth International Symposium on Familial Amyloidotic Polyneuropathy. Nov 15, 2011 1616
Alnylam Pharmaceuticals Reports Third Quarter 2011 Financial Results. Financial report Nov 1, 2011 8385
Intellect Neurosciences Announces Its New CONJUMAB-A Platform Technology for Novel Treatments of Alzheimer's Disease and Other Proteinopathies. Oct 26, 2011 952
RIKEN: Peptide Reveals Clues to Causes of Alzheimer's Disease. Disease/Disorder overview Jul 4, 2011 458
Alnylam Presents New Data from ALN-TTR Program at Peripheral Nerve Society Meeting. Jun 28, 2011 1826
Isis Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone Payment From GlaxoSmithKline. May 19, 2011 1190
Localized oropharyngeal amyloidosis. Grindle, Christopher R.; Curry, Joseph M.; Cantor, Joshua P.; Malloy, Kelly M.; Pribitkin, Edmund A. Case study May 1, 2011 1296
Alzheimer's prevention research gets a boost: private initiative enrolling more than 50,000 subjects for two studies testing amyloid hypothesis. Jancin, Bruce Apr 1, 2011 1035
FDA, Leading Stakeholders in CNS Drug Development Address Concerns Regarding Amyloid Hypothesis in Alzheimer's Disease. Feb 22, 2011 530
Alnylam Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis. Jan 25, 2011 1836
Chronic Familial Mediterranean Fever with development of secondary amyloidosis. Larrimore, Christopher Disease/Disorder overview Jan 1, 2011 3172
Amyloidosis; diagnosis and treatment. Book review Dec 1, 2010 136
New criteria may hasten identification of AD. Sullivan, Michele G. Report Oct 1, 2010 1179
A case of multiple myeloma diagnosed by skin lesions/Deri bulgulari ile tani konulan bir multipl myelom olgusu. Erdogan, Fatma Gulru; Tugrul, Burcu; Gurler, Aysel; Heper, Aylin Okcu Report Sep 1, 2010 1594
Abnormal protein. Aug 7, 2010 130
Alnylam to Webcast Virtual RNAi Roundtable on ALN-TTR for Treatment of Transthyretin-Mediated Amyloidosis. Discussion Jul 19, 2010 397
Alnylam Initiates Dosing in Phase I Clinical Study of ALN-TTR01 in Patients with Transthyretin-Mediated Amyloidosis (ATTR). Jul 7, 2010 1424
Alnylam Obtains Approvals to Initiate Phase I Study with ALN-TTR01 in Patients with TTR-Mediated Amyloidosis (ATTR). Jun 29, 2010 1204
BELLUS HEALTH/CELTIC THERAPEUTICS DEVELOP KIACTA. Clinical report Jun 1, 2010 1292
Mayo Clinic Discovers Mutation Causing Protein Misfolding Remission. May 19, 2010 652
Mayo Clinic Discovers Mutation Causing Protein Misfolding Remission. May 11, 2010 685
Amyloidosis of the external auditory canal. Klemens, James J.; Recant, Wendy; Baron, Joseph M.; Saadia-Redleaf, Miriam I. Case study May 1, 2010 967
BELLUS Health and Celtic Therapeutics enter agreement for BELLUS' drug candidate KIACTA(TM). Clinical report Apr 29, 2010 1720
Alnylam and Collaborators Demonstrate Regression of Pathogenic Transthyretin (TTR) Amyloid Deposits Following Treatment with an RNAi Therapeutic in an Animal Model of TTR-Mediated Amyloidosis (ATTR). Apr 20, 2010 1478
Subcutaneous [beta]2-microglobulin amyloid shoulder nodules in a long-term hemodialysis patient. Mendoza, Paul D.; Fenves, Andrew Z.; Punar, Metin; Stone, Marvin J. Case study Apr 1, 2010 1326
Renal diseases with organized deposits: an algorithmic approach to classification and clinicopathologic diagnosis. Herrera, Guillermo A.; Turbat-Herrera, Elba A. Apr 1, 2010 10247
A proposed histopathologic classification, scoring, and grading system for renal amyloidosis: standardization of renal amyloid biopsy report. Sen, Sait; Sarsik, Banu Report Apr 1, 2010 9162
Amyloidosis--where are we now and where are we heading? Picken, Maria M. Report Apr 1, 2010 5479
Alnylam and Collaborators Present Data from Multiple Pre-Clinical and Clinical Programs at RNAi Keystone Symposium. Jan 19, 2010 2170
Alnylam Presents New Pre-Clinical Data on ALN-TTR, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis. Nov 2, 2009 1169
Dimebon's action may challenge amyloid theory. Sullivan, Michele G. Nov 1, 2009 828
Review: structure of amyloid fibril in diseases. Ghahghaei, Arezou; Faridi, Nasim Report Sep 1, 2009 9466
Alnylam Pharmaceuticals Reports Second Quarter 2009 Financial Results. Financial report Aug 6, 2009 4180
Light chain amyloidosis: a case presentation and review. Melmed, Gavin M. Case study Jul 1, 2009 2656
AL amyloidosis added to agent orange presumptive disabilities. Brief article Jul 1, 2009 256
Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens: common, harmful, yet underappreciated. Henriksen, Kammi J.; Meehan, Shane M.; Chang, Anthony Report Jul 1, 2009 11169
Renowned Professor Traces the Effects of Green Darjeeling Tea While Improving His Own Amyloidosis Illness. Apr 13, 2009 290
Chris' Journey; A son honors his mother's courage by biking the East Coast. Mar 4, 2009 848
FoldRx to Raise Awareness of TTR Amyloidosis in Conjunction with NORD's Rare Diseases Day. Feb 26, 2009 664
Alnylam and Collaborators Present Data from Multiple Pre-Clinical and Clinical Programs at RNAi Keystone Symposium. Feb 12, 2009 2643
Amyloid theory of Alzheimer's not dead--yet. Sullivan, Michele G. Jan 1, 2009 1081
A case of familial lichen amyloidosis/Ailesel liken amiloidoz olgusu. Ergin, Seniz; Demirkan, Nese; Kacar, Nida; Erdogan, Berna Sanli; Akman, Hatice Case study Dec 1, 2008 1096
A case report of systemic amyloidosis with lung involvement/ Akciger tutulumu olan sistemik amiloidoz olgu sunumu. Sen, Elif; Kaya, Akin; Kilickap, Mustafa; Ulger, Fusun; Erekul, Selim; Kervancioglu, Celal; Demirel, Case study Dec 1, 2008 1843
Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program. Nov 20, 2008 1071
Alnylam Pharmaceuticals Reports Third Quarter 2008 Financial Results. Financial report Nov 5, 2008 3881
FoldRx Announces Rapid Progress with Development Program for Lead Candidate. Clinical report Oct 7, 2008 1101
Laryngeal amyloidosis: a case of 'Adidas-stripes' larynx. Desuter, Gauthier; Hamoir, Marc; Van Geem, Christophe; Boucquey, Donatienne Jul 1, 2007 162
FoldRx Announces Its Phase II/III Clinical Study with Lead Clinical Candidate. Clinical report May 29, 2007 935
Combined cardiac and liver transplantation for the treatment of familial amyloidosis. Schwartz, Brian G.; Kuiper, Johannes J.; Klintmalm, Goran B.; Stone, Marvin J.; Schussler, Jeffrey M Clinical report Apr 1, 2007 1890
Surgical rehabilitation for primary laryngeal amyloidosis. Osborne, Ryan F. Apr 1, 2007 476
Amyloidosis of the external auditory canal and middle ear: unusual ear tumor. O'Sullivan, Timothy J. Disease/Disorder overview Feb 1, 2007 1263
Hypertrophic cardiomyopathy and symptomatic conduction system disease in cardiac amyloidosis. Woodlock, Timothy J. Clinical report Dec 1, 2006 1821
Pruritic eruption on the anterior shins. Cather, Jennifer Clay Clinical report Oct 1, 2006 913
Neurochem Marketing Authorization Application for Kiacta(TM) Accepted for Review by EMEA. Sep 28, 2006 756
FoldRx Pharmaceuticals Closes $43 Million Series B Financing; Funds Will Advance Clinical Development of the Lead Compound, Fx-1006A, and the Company's Pre-Clinical Pipeline. May 30, 2006 672
Occipital region hardest hit by cerebral amyloid angiopathy. Wachter, Kerri Mar 1, 2006 680
Primary cutaneous nodular amyloidosis in a patient with Sjogren's syndrome. Srivastava, Monika Mar 1, 2006 833
Multiplex molecular diagnosis of MEFV mutations in patients with Familial Mediterranean fever by Lightcycler real-time PCR. Rossou, Elena; Kouvatsi, Anastasia; Aslanidis, Charalampos; Deltas, Constantinos Sep 1, 2005 2535
Quantification of cleaved [[beta].sub.2]-microglobulin in serum from patients undergoing chronic hemodialysis. Corlin, Dorthe B.; Sen, Jette W.; Ladefoged, Soren; Lund, Grethe Bjerregaard; Nissen, Mogens H.; Hee Jul 1, 2005 5141
Macroglossia secondary to systemic amyloidosis: case report and literature review. Muller, Helena Jun 1, 2005 2673
Diagnostic performance of quantitative [kappa] and [lambda] free light chain assays in clinical practice. Katzmann, Jerry A.; Abraham, Roshini S.; Dispenzieri, Angela; Lust, John A.; Kyle, Robert A. Clinical report May 1, 2005 2518
CMS begins Medicare coverage of using AuSCT for (AL) Amyloidosis patients. Brief Article Mar 31, 2005 275
Neural protein may stop the progression of Alzheimer disease. Phelps, Jerry Jan 1, 2005 383
Amyloid tumor of the larynx associated with plasma cell infiltration: differential diagnosis. Maier, Wolfgang Dec 1, 2004 2452
Detection of genetic variants of transthyretin by liquid chromatography-dual electrospray ionization Fourier-transform ion-cyclotron-resonance mass spectrometry. Nepomuceno, Angelito I.; Mason, Christopher J.; Muddiman, David C.; Bergen, H. Robert, III; Zeldenru Sep 1, 2004 5897
Identification of transthyretin variants by sequential proteomic and genomic analysis. Bergen, H. Robert, III; Zeldenrust, Steven R.; Butz, Malinda L.; Snow, Denise S.; Dyck, Peter J.; Dy Sep 1, 2004 6150
Larynx amyloidosis. Thompson, Lester D.R. Nov 1, 2003 346
Bone marrow amyloidosis with erythropoietin-resistant anemia in a patient undergoing chronic hemodialysis treatment. (Case Report). Kaya, Hasan May 1, 2003 1652
Familial Mediterranean fever. Bilen, Habib Dec 1, 2002 2734
Serum reference intervals and diagnostic ranges for free [kappa] and free [lambda] immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Katzmann, Jerry A.; Clark, Raynell J.; Abraham, Roshini S.; Bryant, Sandra; Lymp, James F.; Bradwell Sep 1, 2002 5225
Multiple myeloma-associated amyloidosis manifesting as fulminant hepatic failure. Wortmann, Glenn W. Oct 1, 2001 1161
Localized laryngotracheobronchial amyloidosis:case report and review of the literature. Weissler, Mark C. Sep 1, 2001 2368
Amyloidosis of the larynx. Hawkshaw, Mary Brief Article Jun 1, 2001 331
Sensitive method for detection and semiquantification of Bence Jones protein by cellulose acetate membrane electrophoresis using colloidal silver staining. Matsuda, Kazuyuki; Hiratsuka, Nobuo; Koyama, Takatoshi; Kurihara, Yuriko; Hotta, Osamu; Itoh, Yoshih Apr 1, 2001 2030
Computer-supported detection of M-components and evaluation of immunoglobulins after capillary electrophoresis. Jonsson, Magnus; Carlson, Joyce; Jeppsson, Jan-Olof; Simonsson, Per Jan 1, 2001 5019
AMYLOIDOSIS PRODUCED BY INJECTIONS OF PROTEINS(*). JAFFE, RICHARD H. Jan 1, 2001 4158
The Changing Concepts of Amyloid. Picken, Maria M. Jan 1, 2001 4688
Rapid method to characterize mutations in transthyretin in cerebrospinal fluid from familial amyloidotic polyneuropathy patients by use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Bergquist, Jonas; Andersen, Oluf; Westman, Ann Sep 1, 2000 4639
Recent insights into the biology of Alzheimer's disease. Banner, Carl Sep 22, 1992 2844

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles